More than three-dozen babies have been sickened in an infant botulism outbreak tied to contaminated formula, federal health ...

An infant botulism outbreak has sickened at least 39 babies across the U.S. and underscored the crucial role of a medication ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

The drug uses antibodies from volunteers vaccinated against botulism to help babies too young to fight the disease on their ...

Convalescent plasma does not reduce the risk of intubation or death in COVID-19 patients, according to a study which found that people receiving the therapy experienced more serious adverse events ...

An immune and cancer cell-targeting antibody therapy has shown potential to eradicate residual traces of deadly blood cell cancer, multiple myeloma, according to interim results from a clinical trial.

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration on Thursday approved Kura Oncology (KURA.O), opens new tab and Japanese partner Kyowa Kirin's (4151.T), opens new tab once-daily pill, Komzifti ...